scholarly journals Statin Therapy in HIGH-Risk Individuals with NORMal Coronary Arteries: The HIGH-NORM Study

Author(s):  
Kyeong-Hyeon Chun ◽  
Jung Mi Park ◽  
Chan Joo Lee ◽  
Jaewon Oh ◽  
Sungha Park ◽  
...  
2018 ◽  
Vol 37 (1) ◽  
pp. 151-161 ◽  
Author(s):  
Ling Zhang ◽  
Andreas Wahle ◽  
Zhi Chen ◽  
John J. Lopez ◽  
Tomas Kovarnik ◽  
...  

2019 ◽  
Vol 17 (2) ◽  
pp. 153-157
Author(s):  
A. Z. Sharafeev ◽  
◽  
A. F. Khalirakhmanov ◽  
A. I. Alkhazurov ◽  
E. A. Gaziev ◽  
...  

Circulation ◽  
1997 ◽  
Vol 95 (4) ◽  
pp. 892-898 ◽  
Author(s):  
Barbara K. Julius ◽  
Martin Spillmann ◽  
Giuseppe Vassalli ◽  
Bruno Villari ◽  
Franz R. Eberli ◽  
...  

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
P.M. Azevedo ◽  
J. Guedes ◽  
J. Bispo ◽  
D. Bento ◽  
D. Carvalho ◽  
...  

2021 ◽  
Vol 10 (7) ◽  
pp. 1480
Author(s):  
Keishi Ichikawa ◽  
Toru Miyoshi ◽  
Kazuhiro Osawa ◽  
Takashi Miki ◽  
Hiroshi Ito

Objective: To evaluate the association of serum malondialdehyde low-density lipoprotein (MDA-LDL), an oxidatively modified LDL, with the prevalence of high-risk plaques (HRP) determined with coronary computed tomography angiography (CTA) in statin-treated patients. Methods: This study was a single-center retrospective cohort comprising 268 patients (mean age 67 years, 58% men) with statin therapy and who underwent coronary CTA for suspected stable coronary artery disease. Patients were classified into two groups according to median MDA-LDL level or median LDL-C level. Coronary CTA-verified HRP was defined when two or more characteristics, including positive remodeling, low-density plaques, and spotty calcification, were present. Results: Patients with HRP had higher MDA-LDL (p = 0.011), but not LDL-C (p = 0.867) than those without HRP. High MDA-LDL was independently associated with HRP (odds ratio 1.883, 95% confidential interval 1.082–3.279) after adjustment for traditional risk factors. Regarding incremental value of MDA-LDL for predicting CTA-verified HRP, addition of serum MDA-LDL levels to the baseline model significantly increased global chi-square score from 26.1 to 32.8 (p = 0.010). Conclusions: A high serum MDA-LDL level is an independent predictor of CTA-verified HRP, which can lead to cardiovascular events in statin-treated patients.


Sign in / Sign up

Export Citation Format

Share Document